Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Operating Expenses (2016 - 2025)

Apyx Medical's Operating Expenses history spans 15 years, with the latest figure at $12.0 million for Q4 2025.

  • For Q4 2025, Operating Expenses changed 0.2% year-over-year to $12.0 million; the TTM value through Dec 2025 reached $39.5 million, down 18.08%, while the annual FY2025 figure was $39.5 million, 18.08% down from the prior year.
  • Operating Expenses reached $12.0 million in Q4 2025 per APYX's latest filing, up from $9.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $14.7 million in Q4 2023 to a low of $8.7 million in Q1 2025.
  • Average Operating Expenses over 5 years is $12.1 million, with a median of $12.3 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: surged 41.92% in 2021, then crashed 30.63% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $13.8 million in 2021, then grew by 2.39% to $14.2 million in 2022, then grew by 3.68% to $14.7 million in 2023, then fell by 18.26% to $12.0 million in 2024, then decreased by 0.2% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Operating Expenses are $12.0 million (Q4 2025), $9.1 million (Q3 2025), and $9.7 million (Q2 2025).